Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- The Global Impact Factor (GIF)
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Yuji Mano
Department of Drug Delivery Research, Kyoto University, Kyoto, Japan
Biography
Dr. Kazuo Hiroshi is a leading pharmaceutical scientist and innovator in the field of drug development, specializing in the treatment of rare diseases and the application of biotechnology in personalized medicine. With a background in molecular pharmacology, Dr. Hiroshi earned his Ph.D. from the University of Kyoto, where his pioneering research into drug resistance mechanisms in cancer cells laid the groundwork for his future endeavors.
For over 20 years, Dr. Hiroshi has contributed significantly to the advancement of pharmaceutical therapies. His work has led to the development of novel small-molecule drugs targeting cancer and neurodegenerative diseases, which are now in clinical trials across multiple countries. He is known for his research into optimizing drug delivery systems using nanotechnology, significantly improving the bioavailability and efficacy of treatments for chronic diseases such as Alzheimer's and Parkinson's disease.
Dr. Hiroshi has published over 150 research papers in top-tier journals such as Journal of Pharmaceutical Sciences, Cancer Research, and The Lancet Oncology. His groundbreaking study on a new class of enzyme inhibitors was pivotal in designing drugs that target tumor microenvironments without affecting healthy tissues, a breakthrough in minimizing side effects associated with chemotherapy.
As an advocate for integrating AI into drug discovery, Dr. Hiroshi currently serves as the Director of the Pharmaceutical Innovation Research Institute, where he leads cross-disciplinary teams in exploring the potential of machine learning and artificial intelligence to accelerate drug development. He has been a speaker at numerous international conferences, sharing his expertise on the future of drug discovery and the role of biotechnology in personalized medicine.
In addition to his research, Dr. Hiroshi has authored several influential books, including The Future of Medicine: Biotechnology and Beyond, which explores the evolving relationship between drug design and technological innovation. His contributions have earned him numerous awards, including the prestigious International Pharmaceutical Research Award.
Publications
-
Commentary Article
Ethical Considerations in Drug Costs: Finding a Balance Between Profit and Accessibility
Author(s): Yuji Mano*